157 related articles for article (PubMed ID: 35476024)
1. The Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on Substance Use in the United States.
Ross JA; Malone PK; Levy S
Clin Infect Dis; 2022 Aug; 75(Suppl 1):S81-S85. PubMed ID: 35476024
[TBL] [Abstract][Full Text] [Related]
2. Substance use during the COVID-19 pandemic: What is really happening?
Mellos E; Paparrigopoulos T
Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
[TBL] [Abstract][Full Text] [Related]
3. The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.
Niles JK; Gudin J; Radcliff J; Kaufman HW
Popul Health Manag; 2021 Feb; 24(S1):S43-S51. PubMed ID: 33031013
[TBL] [Abstract][Full Text] [Related]
4. Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review.
Layman HM; Thorisdottir IE; Halldorsdottir T; Sigfusdottir ID; Allegrante JP; Kristjansson AL
Curr Psychiatry Rep; 2022 Jun; 24(6):307-324. PubMed ID: 35476186
[TBL] [Abstract][Full Text] [Related]
5. The Effects of the COVID-19 Pandemic on the Risk of Youth Substance Use.
Richter L
J Adolesc Health; 2020 Oct; 67(4):467-468. PubMed ID: 32773298
[No Abstract] [Full Text] [Related]
6. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.
Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I
Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181
[TBL] [Abstract][Full Text] [Related]
7. Early Adolescent Substance Use Before and During the COVID-19 Pandemic: A Longitudinal Survey in the ABCD Study Cohort.
Pelham WE; Tapert SF; Gonzalez MR; McCabe CJ; Lisdahl KM; Alzueta E; Baker FC; Breslin FJ; Dick AS; Dowling GJ; Guillaume M; Hoffman EA; Marshall AT; McCandliss BD; Sheth CS; Sowell ER; Thompson WK; Van Rinsveld AM; Wade NE; Brown SA
J Adolesc Health; 2021 Sep; 69(3):390-397. PubMed ID: 34452728
[TBL] [Abstract][Full Text] [Related]
8. Excess Fatal Overdoses in the United States During the COVID-19 Pandemic by Geography and Substance Type: March 2020-August 2021.
Chandra J; Charpignon ML; Bhaskar A; Therriault A; Chen YH; Mooney A; Dahleh MA; Kiang MV; Dominici F
Am J Public Health; 2024 Jun; 114(6):599-609. PubMed ID: 38718338
[No Abstract] [Full Text] [Related]
9. Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period.
Jones HE; Hairston E; Lensch AC; Marcus LK; Heil SH
Prev Med; 2021 Nov; 152(Pt 2):106742. PubMed ID: 34302836
[TBL] [Abstract][Full Text] [Related]
10. Changes in characteristics of drug overdose death trends during the COVID-19 pandemic.
DiGennaro C; Garcia GP; Stringfellow EJ; Wakeman S; Jalali MS
Int J Drug Policy; 2021 Dec; 98():103392. PubMed ID: 34325184
[TBL] [Abstract][Full Text] [Related]
11. The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data.
Imtiaz S; Nafeh F; Russell C; Ali F; Elton-Marshall T; Rehm J
Subst Abuse Treat Prev Policy; 2021 Nov; 16(1):87. PubMed ID: 34844624
[TBL] [Abstract][Full Text] [Related]
12. The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.
Bennett AS; Townsend T; Elliott L
Int J Drug Policy; 2022 Mar; 101():103554. PubMed ID: 34911010
[TBL] [Abstract][Full Text] [Related]
13. Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States.
Auty SG; Griffith KN
Drug Alcohol Depend; 2022 Mar; 232():109340. PubMed ID: 35131533
[TBL] [Abstract][Full Text] [Related]
14. Changes in Emergency Medical Services Before and During the COVID-19 Pandemic in the United States, January 2018-December 2020.
Handberry M; Bull-Otterson L; Dai M; Mann NC; Chaney E; Ratto J; Horiuchi K; Siza C; Kulkarni A; Gundlapalli AV; Boehmer TK
Clin Infect Dis; 2021 Jul; 73(Suppl 1):S84-S91. PubMed ID: 33956123
[TBL] [Abstract][Full Text] [Related]
15. Converging public health crises: substance use during the coronavirus disease 2019 pandemic.
Striley CW; Hoeflich CC
Curr Opin Psychiatry; 2021 Jul; 34(4):325-331. PubMed ID: 34001699
[TBL] [Abstract][Full Text] [Related]
16. [Consequences of the COVID-19 pandemic for people with schizophrenia, dementia and substance use disorders].
Adorjan K; Haussmann R; Rauen K; Pogarell O
Nervenarzt; 2021 Jun; 92(6):571-578. PubMed ID: 33779773
[TBL] [Abstract][Full Text] [Related]
17. Safer opioid distribution in response to the COVID-19 pandemic.
Tyndall M
Int J Drug Policy; 2020 Sep; 83():102880. PubMed ID: 32739148
[TBL] [Abstract][Full Text] [Related]
18. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19.
Brothers S; Viera A; Heimer R
J Subst Abuse Treat; 2021 Dec; 131():108449. PubMed ID: 34098303
[TBL] [Abstract][Full Text] [Related]
19. Trends in Substance-Related Visits Among Youth to US Children's Hospitals, 2016-2021: An Analysis of the Pediatric Health Information System Database.
Ball A; Hadland S; Rodean J; Hall M; Mendoza J; Ahrens K
J Adolesc Health; 2024 Jul; 75(1):76-84. PubMed ID: 38530681
[TBL] [Abstract][Full Text] [Related]
20. Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis.
Lee Y; Lui LMW; Brietzke E; Liao Y; Lu C; Ho R; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
J Affect Disord; 2022 Jan; 296():514-521. PubMed ID: 34656039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
